Search

Thomas E. Denion

Supervisory Patent Examiner (ID: 8996, Phone: (571)272-4859 , Office: P/3748 )

Most Active Art Unit
3401
Art Unit(s)
3401, 3748, 3727, 3745
Total Applications
1565
Issued Applications
1326
Pending Applications
55
Abandoned Applications
184

Applications

Application numberTitle of the applicationFiling DateStatus
10/018314 Structure-based design of compounds that inhibit detrimental cytotoxic t lymphocyte responses May 21, 2002 Abandoned
Array ( [id] => 6110438 [patent_doc_number] => 20020172681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Modulating Th2 cell levels via vMIP-I/CCR8 interaction' [patent_app_type] => new [patent_app_number] => 10/144883 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9343 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172681.pdf [firstpage_image] =>[orig_patent_app_number] => 10144883 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/144883
Modulating Th2 cell levels via vMIP-I/CCR8 interaction May 13, 2002 Abandoned
Array ( [id] => 6829865 [patent_doc_number] => 20030180923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/139980 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63506 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180923.pdf [firstpage_image] =>[orig_patent_app_number] => 10139980 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/139980
PRO4395 antibodies May 5, 2002 Issued
Array ( [id] => 7405637 [patent_doc_number] => 20040105862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Human TIMP-1 antibodies' [patent_app_type] => new [patent_app_number] => 10/128520 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18978 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105862.pdf [firstpage_image] =>[orig_patent_app_number] => 10128520 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128520
Human TIMP-1 antibodies Apr 23, 2002 Issued
Array ( [id] => 408207 [patent_doc_number] => 07285525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Suppression of immune response via inhibition of cathepsin S' [patent_app_type] => utility [patent_app_number] => 10/126223 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12457 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285525.pdf [firstpage_image] =>[orig_patent_app_number] => 10126223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/126223
Suppression of immune response via inhibition of cathepsin S Apr 18, 2002 Issued
Array ( [id] => 6821579 [patent_doc_number] => 20030219740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'DNA sequences isolated from human colonic epithelial cells' [patent_app_type] => new [patent_app_number] => 10/089887 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44943 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219740.pdf [firstpage_image] =>[orig_patent_app_number] => 10089887 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/089887
DNA sequences isolated from human colonic epithelial cells Mar 28, 2002 Abandoned
Array ( [id] => 5786400 [patent_doc_number] => 20020160019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Identification of broadly reactive DR restricted epitopes' [patent_app_type] => new [patent_app_number] => 10/103395 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 8896 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160019.pdf [firstpage_image] =>[orig_patent_app_number] => 10103395 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/103395
Identification of broadly reactive DR restricted epitopes Mar 19, 2002 Abandoned
Array ( [id] => 645647 [patent_doc_number] => 07119170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases' [patent_app_type] => utility [patent_app_number] => 10/092404 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6996 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119170.pdf [firstpage_image] =>[orig_patent_app_number] => 10092404 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/092404
Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases Mar 3, 2002 Issued
Array ( [id] => 6647395 [patent_doc_number] => 20030104472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antibody specifically binding human pinch protein homolog' [patent_app_type] => new [patent_app_number] => 10/092066 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16088 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104472.pdf [firstpage_image] =>[orig_patent_app_number] => 10092066 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/092066
Antibody specifically binding human pinch protein homolog Mar 3, 2002 Abandoned
Array ( [id] => 6476426 [patent_doc_number] => 20020151707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Immune mediators and related methods' [patent_app_type] => new [patent_app_number] => 10/081281 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30035 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151707.pdf [firstpage_image] =>[orig_patent_app_number] => 10081281 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/081281
Immune mediators and related methods Feb 19, 2002 Abandoned
Array ( [id] => 5907904 [patent_doc_number] => 20020142944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Treatment of ocular disorders' [patent_app_type] => new [patent_app_number] => 10/079931 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3396 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142944.pdf [firstpage_image] =>[orig_patent_app_number] => 10079931 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/079931
Treatment of ocular disorders Feb 18, 2002 Abandoned
Array ( [id] => 7202801 [patent_doc_number] => 20040086960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same' [patent_app_type] => new [patent_app_number] => 10/075257 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086960.pdf [firstpage_image] =>[orig_patent_app_number] => 10075257 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/075257
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same Feb 14, 2002 Abandoned
Array ( [id] => 6258686 [patent_doc_number] => 20020187147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Antigen specific recombinant MHC class II molecules and methods of use' [patent_app_type] => new [patent_app_number] => 10/074257 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 14455 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187147.pdf [firstpage_image] =>[orig_patent_app_number] => 10074257 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/074257
Antigen specific recombinant MHC class II molecules and methods of use Feb 13, 2002 Abandoned
Array ( [id] => 830284 [patent_doc_number] => 07399838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Single chain class I major histo-compatibility complexes' [patent_app_type] => utility [patent_app_number] => 10/073300 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 14883 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399838.pdf [firstpage_image] =>[orig_patent_app_number] => 10073300 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/073300
Single chain class I major histo-compatibility complexes Feb 12, 2002 Issued
Array ( [id] => 961211 [patent_doc_number] => 06951924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Antibodies against secreted protein HTEBYII' [patent_app_type] => utility [patent_app_number] => 10/058993 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 201196 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951924.pdf [firstpage_image] =>[orig_patent_app_number] => 10058993 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/058993
Antibodies against secreted protein HTEBYII Jan 29, 2002 Issued
Array ( [id] => 5858579 [patent_doc_number] => 20020122820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Soluble MHC artificial antigen presenting cells' [patent_app_type] => new [patent_app_number] => 10/050231 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6191 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20020122820.pdf [firstpage_image] =>[orig_patent_app_number] => 10050231 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/050231
Soluble MHC artificial antigen presenting cells Jan 15, 2002 Abandoned
Array ( [id] => 6177713 [patent_doc_number] => 20020156011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Compositions and methods for the therapy and diagnosis of colon cancer' [patent_app_type] => new [patent_app_number] => 10/046935 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38366 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156011.pdf [firstpage_image] =>[orig_patent_app_number] => 10046935 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/046935
Compositions and methods for the therapy and diagnosis of colon cancer Jan 14, 2002 Abandoned
Array ( [id] => 6305360 [patent_doc_number] => 20020094332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Method of prophylaxis against large myocardial infractions' [patent_app_type] => new [patent_app_number] => 10/047608 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3830 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094332.pdf [firstpage_image] =>[orig_patent_app_number] => 10047608 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/047608
Method of prophylaxis against large myocardial infractions Jan 13, 2002 Abandoned
Array ( [id] => 5921759 [patent_doc_number] => 20020115157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof' [patent_app_type] => new [patent_app_number] => 10/045949 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18452 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115157.pdf [firstpage_image] =>[orig_patent_app_number] => 10045949 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/045949
Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof Jan 10, 2002 Issued
09/913756 Tyrosine kinase receptor epha3 antigenic peptides Jan 4, 2002 Abandoned
Menu